Welcome to ESGCT
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.The ESGCT and SFTCG Collaborative Congress 2012 will take place in the beautiful city of Versailles from October 26th to 29th 2012.
To keep up to date with announcements and news, including being alerted when registration for the Versailles congress is open, enter your email address in the ‘Keep Informed’ box at the bottom of this page.
We look forward to seeing you in Versailles!
The programme is now available here.
Click here to register for the congress.
ESGCT AND SFTCG COLLABORATIVE CONGRESS 2012
26 - 29 OctobER 2012, VERSAILLES, FRANCE
|
News, Meetings & Events
Genome Engineering: Research & Applications More information Published: 11 October 2011 Author: ESGCT Further Reading Conference...
European Medicines Agency recommends first gene therapy for approval Glybera offers new medical treatment for patients with severe or multiple...
For more information go to the following website www.cardiovascularcelltherapy.com
Clinical progress in gene therapy: Sustained partial correction of the bleeding disorder in patients suffering from severe hemophilia B More...
The European Medicines Agency has recently released a draft reflection paper on risk based quality management in clinical trials. More...
Gene therapy fulfilling its promise More information Published: 11 May 2009 Author: Thierry VandenDriessche, PhD Dear ESGCT members and...
.png)
No hay comentarios:
Publicar un comentario